Baxter International Inc. (NYSE: BAX) blamed disappointing sales of plasma-based therapies for cutting its 2010 profit guidance. The stock price plunged $8.32 to $50.63.
Baxter Cuts Guidance
April 22, 2010 at 13:31 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.